Case Report

Published on 27 Feb 2024

Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: a case report

in Thoracic Oncology

Zhiming Wu
Zelin Zhang
Dongdong Zhang
Zengyan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1357230

1,050 views
2 citations

Case Report

Published on 23 Feb 2024

Case report: Pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy

in Thoracic Oncology

Yukiko Nemoto
Koji Kuroda
Rintaro Oyama
Masataka Mori
Shohei Shimajiri
Fumihiro Tanaka

Frontiers in Oncology

doi 10.3389/fonc.2024.1290757

1,440 views
2 citations

Systematic Review

Published on 22 Feb 2024

Perioperative immunotherapy for stage II-III non-small cell lung cancer: a meta-analysis base on randomized controlled trials

in Thoracic Oncology

Anping Yu
Feng Fu
Xiongying Li
Mengxin Wu
Meijian Yu
Wenxiong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1351359

3,081 views
1 citation

Case Report

Published on 15 Feb 2024

Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy

in Thoracic Oncology

Quanqing Li
Guangxin Zhang
Hao Yang
Jindong Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1329152

1,113 views

Case Report

Published on 14 Feb 2024

RET gene fusion and emergent Selpercatinib resistance in a calcitonin-rich neuroendocrine carcinoma: a case report

in Thoracic Oncology

Reza Pishdad
Peter B. Illei
Christopher D. Gocke
Douglas W. Ball

Frontiers in Oncology

doi 10.3389/fonc.2024.1360492

1,305 views
1 citation

Review

Published on 13 Feb 2024

The future of artificial intelligence in thoracic surgery for non-small cell lung cancer treatment a narrative review

in Thoracic Oncology

Namariq Abbaker
Fabrizio Minervini
Angelo Guttadauro
Piergiorgio Solli
Ugo Cioffi
Marco Scarci

Frontiers in Oncology

doi 10.3389/fonc.2024.1347464

2,813 views
3 citations

Original Research

Published on 13 Feb 2024

A new, potential and safe neoadjuvant therapy strategy in epidermal growth factor receptor mutation-positive resectable non-small-cell lung cancer-targeted therapy: a retrospective study

in Thoracic Oncology

Baoxing Liu
Xingyu Liu
Huifang Xing
Haibo Ma
Zhenyu Lv
Yan Zheng
Wenqun Xing

Frontiers in Oncology

doi 10.3389/fonc.2024.1349172

1,220 views
1 citation

Case Report

Published on 13 Feb 2024

Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib

in Thoracic Oncology

Nana Huang
Tianhao Qu
Chunxia Zhang
Jia Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1269148

1,742 views
1 citation

Case Report

Published on 12 Feb 2024

Small cell lung cancer with dermatomyositis: a case report

in Thoracic Oncology

Xiaomin Guan
Shi Qiu
Yinghui Xu
Jianjiao Zu
Chao Sun
Ye Guo
Xu Wang
Kewei Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1325991

1,672 views

Original Research

Published on 07 Feb 2024

Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

in Thoracic Oncology

Shenduo Li
Rami Manochakian
Ruqin Chen
Jaydeepbhai Patel
Jyothik Varun Inampudi
Koshiya R. Hiren
Yujie Zhao
Yanyan Lou

Frontiers in Oncology

doi 10.3389/fonc.2024.1306311

1,626 views

Original Research

Published on 07 Feb 2024

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

in Thoracic Oncology

Lauren Julia Brown
Victor Khou
Chris Brown
Marliese Alexander
Dasantha Jayamanne
Joe Wei
Lauren Gray
Wei Yen Chan
Samuel Smith
Susan Harden

Frontiers in Oncology

doi 10.3389/fonc.2024.1305720

2,366 views
1 citation

Case Report

Published on 07 Feb 2024

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC

in Thoracic Oncology

Elisa De Carlo
Elisa Bertoli
Monica Schiappacassi
Brigida Stanzione
Alessandro Del Conte
Roberto Doliana
Michele Spina
Alessandra Bearz

Frontiers in Oncology

doi 10.3389/fonc.2024.1307458

1,390 views
1 citation

Original Research

Published on 02 Feb 2024

The global research of artificial intelligence in lung cancer: a 20-year bibliometric analysis

in Thoracic Oncology

Ruikang Zhong
Tangke Gao
Jinghua Li
Zexing Li
Xue Tian
Chi Zhang
Ximing Lin
Yuehui Wang
Lei Gao
Kaiwen Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1346010

3,427 views
3 citations

Systematic Review

Published on 02 Feb 2024

Clinical efficacy and safety of Chinese herbal injections in combination with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of 140 randomized controlled trials

in Thoracic Oncology

Kangdi Cao
Shuaihang Hu
Dandan Wang
Chenxi Qiao
Zhuo Wang
Jinkun Wang
Wei Hou

Frontiers in Oncology

doi 10.3389/fonc.2024.1307836

1,801 views

Original Research

Published on 31 Jan 2024

Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis

in Thoracic Oncology

Patrizia Ciammella
Salvatore Cozzi
Paolo Borghetti
Marco Galaverni
Valerio Nardone
Maria Paola Ruggieri
Matteo Sepulcri
Vieri Scotti
Alessio Bruni
Francesca Zanelli

Frontiers in Oncology

doi 10.3389/fonc.2024.1325249

1,735 views
1 citation

Original Research

Published on 31 Jan 2024

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data

in Thoracic Oncology

Ningning Yan
Huixian Zhang
Sanxing Guo
Ziheng Zhang
Yingchun Xu
Liang Xu
Xingya Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1353491

1,675 views
1 citation

Navigation group

Articles

Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: a case report

Case report: Pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy

Perioperative immunotherapy for stage II-III non-small cell lung cancer: a meta-analysis base on randomized controlled trials

Rare case report: a case of histological type transformation of lung cancer caused by neoadjuvant immunotherapy

RET gene fusion and emergent Selpercatinib resistance in a calcitonin-rich neuroendocrine carcinoma: a case report

The future of artificial intelligence in thoracic surgery for non-small cell lung cancer treatment a narrative review

A new, potential and safe neoadjuvant therapy strategy in epidermal growth factor receptor mutation-positive resectable non-small-cell lung cancer-targeted therapy: a retrospective study

Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib

Small cell lung cancer with dermatomyositis: a case report

Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy

First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC

The global research of artificial intelligence in lung cancer: a 20-year bibliometric analysis

Clinical efficacy and safety of Chinese herbal injections in combination with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of 140 randomized controlled trials

Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data